Ovarian Seromucinous Tumor — Trials

Ovarian Seromucinous Tumor — Trials · CancerIndex

Clinical trials

Registered studies

28 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00989651	Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer	completed	Phase 1	431	National Cancer Institute (NCI)NIH	1	Oct 20, 2021	clinicaltrials
NCT01074411	Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer	completed	Phase 1	33	National Cancer Institute (NCI)NIH	1	Aug 9, 2019	clinicaltrials
NCT01459380	Pegylated Liposomal Doxorubicin Hydrochloride, Carboplatin, Veliparib, and Bevacizumab in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer	completed	Phase 1	41	National Cancer Institute (NCI)NIH	1	Jul 22, 2019	clinicaltrials

Data updated 22 days agoSource updated Oct 20, 2021source: clinicaltrials